Lite Strategy, Inc. (NASDAQ: LITS) has shifted from passive to active capital management, utilizing its 929,548 Litecoin (LTC) holdings valued at $28.3 million as of November 15, 2025. The company, previously known as MEI Pharma, holds no outstanding debt and maintains $12.21 million in working capital. Additionally, Lite Strategy has announced a $25 million share buyback plan to leverage its net asset value discount. The active management strategy, overseen by GSR, marks a departure from the passive approach typical of most cryptocurrency ETFs. This move aligns with the growing trend of institutional adoption of digital assets, positioning Lite Strategy to potentially enhance returns through strategic asset management.